Wiley Bros. Aintree Capital, LLC Teva Pharmaceutical Industries LTD Transaction History
Wiley Bros. Aintree Capital, LLC
- $5.07 Billion
- Q3 2024
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 33,349 shares of TEVA stock, worth $747,684. This represents 0.01% of its overall portfolio holdings.
Number of Shares
33,349Holding current value
$747,684% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding TEVA
# of Institutions
625Shares Held
573MCall Options Held
19.6MPut Options Held
6.77M-
Black Rock Inc. New York, NY43MShares$964 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.2MShares$813 Million35.87% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L334.5MShares$774 Million5.5% of portfolio
-
Menora Mivtachim Holdings Ltd.28.8MShares$647 Million3.32% of portfolio
-
Exor Capital LLP London, X026.5MShares$594 Million14.79% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $24.9B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...